Literature DB >> 30189985

Painful Oral Lesions.

Istvan A Hargitai1.   

Abstract

Painful oral vesiculoerosive diseases (OVD) include lichen planus, pemphigus vulgaris, mucous membrane pemphigoid, erythema multiforme, and recurrent aphthous stomatitis. OVD lesions have an immunopathic cause. Treatment is aimed at reducing the immunologic and the following inflammatory response. The mainstay of OVD management is topical or systemic corticosteroids to include topical triamcinolone, fluocinonide, and clobetasol, whereas systemic medications used in practice can include dexamethasone, prednisone, and prednisolone. Oral herpetic lesions can be primary or recurrent. If management is desired, they can be treated by topical or systemic antiviral drugs. Topical antiviral creams include prescription acyclovir, penciclovir and over-the-counter docosanol. Published by Elsevier Inc.

Entities:  

Keywords:  Aphthous ulcer; Herpes labialis; Vesiculobullous; Vesiculoerosive

Mesh:

Year:  2018        PMID: 30189985     DOI: 10.1016/j.cden.2018.06.002

Source DB:  PubMed          Journal:  Dent Clin North Am        ISSN: 0011-8532


  3 in total

1.  Integrating piezoresistive sensors on the embouchure analysis of the lower lip in single reed instrumentalists: implementation of the lip pressure appliance (LPA).

Authors:  Miguel Pais Clemente; Joaquim Mendes; Joana Cerqueira; André Moreira; Mário Vasconcelos; Afonso Pinhão Ferreira; José Manuel Amarante
Journal:  Clin Exp Dent Res       Date:  2019-09-05

Review 2.  Hydroxychloroquine and the treatment of Sjogren syndrome, chronic ulcerative stomatitis, and oral lichen planus in the age of COVID-19.

Authors:  Heba Hussein; Ronald Brown
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2020-06-20

3.  Effect of the intra-alveolar administration of dexamethasone on swelling, trismus, and pain after impacted lower third molar extraction: a randomized, double-blind clinical trial.

Authors:  R-V Marques; L-S Branco-de-Almeida; D-M Marques; I-C Oliveira; S-J Mendes; V-P Rodrigues; F-F Lopes
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2022-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.